{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:40:46Z","timestamp":1784936446657,"version":"3.55.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Monkeypox (MPX) was first reported in 1970 in humans and outbreaks were restricted and highly localised to endemic regions of western and central Africa. However, after the first reported case in the UK in early May, 2022, the pattern of epidemic spreading in the geographical regions was much larger compared to past, posing a risk MPX might become entrenched beyond endemic areas. This virus is less transmissible than SARS-CoV-2, as it transmitted mainly through personal, close, often skin-to-skin contact with infectious MPX rash, body fluids, or scabs from an individual with MPX. Infections usually present with chills, fever, fatigue, muscle aches, headache, sore throat, skin lesions, and lymphadenopathy. Currently, there are no antivirals approved for MPX. However, an antiviral drug called \u201ctecovirimat,\u201d approved for the treatment of smallpox, has been made accessible to treat MPX. Moreover, to prevent MPX, there are two vaccines available which are approved by FDA: Bavarian Nordic JYNNEOS, and ACAM2000 vaccine. Contact tracing is absent in case of MPX outbreak and there is lack of information from the data systems in rapid manner. Additionally, test capacity needs to be increased. Like SARS-CoV-2, global MPX outbreak demand for vaccines far exceeds availability.<\/jats:p>","DOI":"10.3389\/fmicb.2022.1037583","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T09:57:35Z","timestamp":1668074255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Comprehensive update on the monkeypox outbreak"],"prefix":"10.3389","volume":"13","author":[{"given":"Asad Mustafa","family":"Karim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujahid Aizaz","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeb","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Chan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3390\/v14091870","article-title":"A glance at the development and patent literature of tecovirimat: the first-in-class therapy for emerging monkeypox outbreak","volume":"14","author":"Almehmadi","year":"2022","journal-title":"Viruses"},{"key":"ref2","year":""},{"key":"ref3","year":""},{"key":"ref4","year":""},{"key":"ref5","year":""},{"key":"ref6","year":""},{"key":"ref7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jama.2022.10802","article-title":"Monkeypox in 2022: what clinicians need to know","volume":"328","author":"Guarner","year":"2022","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1473-3099(22)00513-8","article-title":"Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding","volume":"22","author":"Lapa","year":"2022","journal-title":"Lancet. Infect. Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/infdis\/jix260","article-title":"Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo","volume":"216","author":"Mbala","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijid.2022.08.016","article-title":"Monkeypox outbreak: a perspective on Africa's diagnostic and containment capacity","volume":"123","author":"Moyo","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/jama.2022.12513","article-title":"The WHO declaration of monkeypox as a global health emergency","volume":"328","author":"Nuzzo","year":"2022","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(22)01487-8","article-title":"Evidence of human-to-dog transmission of monkeypox virus","volume":"400","author":"Seang","year":"2022","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study","volume":"400","author":"Tar\u00edn-Vicente","year":"2022","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries: N","volume":"387","author":"Thornhill","year":"2022","journal-title":"Engl. J. Med."},{"key":"ref13","year":"2022"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1037583\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T09:57:37Z","timestamp":1668074257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1037583\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":15,"alternative-id":["10.3389\/fmicb.2022.1037583"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.1037583","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"1037583"}}